Ralph A. DeFronzo

71.0k citations
427 papers · 52.3k indexed · 24 hit papers · h-index 113

Impact in

    • Diabetes Treatment and Management
    • Diabetes Management and Research
    • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Physiology top 0.01%
    • Adipose Tissue and Metabolism
    • Diet and metabolism studies

Papers in

    • Diabetes Treatment and Management 104
    • Diabetes Management and Research 82
    • Diabetes, Cardiovascular Risks, and Lipoproteins 34
    • Diet and metabolism studies 73
    • Adipose Tissue and Metabolism 69

Ralph A. DeFronzo

414 papers receiving 50.2k citations

Hit Papers

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors 2021 · 382 citations
382197620261992200950010001.5k2.0k

Peers

Ralph A. DeFronzo
Comparison fields: 5 of 189
  • Endocrinology, Diabetes and Metabolism 24.6k
  • Physiology 17.7k
  • Endocrine and Autonomic Systems 2.1k
  • Molecular Biology 21.0k
  • Cell Biology 4.8k
Replace Markku Laakso with:
Markku Laakso Finland
Gerald M. Reaven United States
Ralph A. DeFronzo United States
Ele Ferrannini Italy
Steven E. Kahn United States
Jerrold M. Olefsky United States
Bart Staels France
James R. Sowers United States
Leif Groop Sweden
Peter Arner Sweden
Ralph A. DeFronzo relative to Markku Laakso Finland Markku Laakso's profile →
Citations per field
00.5×2.6×
Markku Laakso · 1×
Citations per year

Countries citing papers authored by Ralph A. DeFronzo

Since Specialization
Citations

This map shows the geographic impact of Ralph A. DeFronzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph A. DeFronzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph A. DeFronzo more than expected).

Fields of papers citing papers by Ralph A. DeFronzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph A. DeFronzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph A. DeFronzo. The network helps show where Ralph A. DeFronzo may publish in the future.

Co-authors

The 25 scholars most cited alongside Ralph A. DeFronzo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ralph A. DeFronzo Line = papers co-authored together Ralph A. DeFronzo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20242
3 20241
4 20232
5 20233
6 202135
7
Abstract 15099: The Economic Burden of Insulin Resistance, Obesity, and Cardiovascular Disease in Medicare Beneficiaries 65 Years of Age and Older
20171
8 201223
9
Metformin: A review of its metabolic effects
1998243
10
Diabetic nephropathy: Etiologic and therapeutic considerations
199556
11 199410
12 1994252
13
Drugs and diabetes
199424
14 1993120
15
The association of hypertension, diabetes, and obesity: A review
198962
16
Kaliuretic effect of dexamethasone. A property unrelated to mineralocorticoid activity
19821
17
Intravenous potassium chloride therapy
19812
18
Insulinopenic hyperkalemia: Regulatory role of basal insulin levels in potassium homeostasis
19771
19
Functional abnormalities in renal cystic diseases.
19762
20
Effects of phlorizin and insulin on tubular phosphate reabsorption. Evidence for two transport pathways
19754

About Ralph A. DeFronzo

Ralph A. DeFronzo is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Endocrine and Autonomic Systems, Clinical Biochemistry and Cell Biology, having authored 427 papers that have together received 52.3k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (146 papers), Diabetes Treatment and Management (104 papers), Diabetes Management and Research (82 papers), Pancreatic function and diabetes (78 papers), Diet and metabolism studies (73 papers), Adipose Tissue and Metabolism (69 papers), Muscle metabolism and nutrition (46 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (24.6k citations), Physiology (17.7k citations), Endocrine and Autonomic Systems (2.1k citations), Molecular Biology (21.0k citations) and Cell Biology (4.8k citations). Ralph A. DeFronzo has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Eleuterio Ferrannini, Devjit Tripathy, Muhammad Abdul‐Ghani, Kenneth Cusi, Riccardo C. Bonadonna, Donald C. Simonson, Lawrence J. Mandarino, Ele Ferrannini, J. Wahren and Amalia Gastaldelli. Their work appears in journals such as Diabetes, Diabetes Care, American Journal of Physiology-Endocrinology and Metabolism, Metabolism and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026